Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Ceska Gynekol ; 83(2): 123-126, 2018.
Article in Czech | MEDLINE | ID: mdl-29869511

ABSTRACT

OBJECTIVE: We present a case report of a patient with cerebral venous thrombosis during pregnancy. DESIGN: Case report. SETTING: Department of Gynaecology and Obstetrics at the Silesian Hospital. METHODS: Own observation, review of literature. CONCLUSION: In any tonic-clonic convulsions in pregnancy, we mainly think of an eclamptic attack and pregnancy must be ended. In case of persistent problems in the postpartum period after stabilization of the patients, differential etiology of convulsive states such as epileptic seizure, hypoglycemic spasms, CNS tumor, intracranial bleeding, cerebrovascular accident or cocaine overdose must be considered within the differential diagnosis.


Subject(s)
Intracranial Thrombosis/diagnosis , Pregnancy Complications, Cardiovascular/diagnosis , Venous Thrombosis/diagnosis , Adult , Diagnosis, Differential , Female , Humans , Pregnancy
2.
Ceska Gynekol ; 82(3): 206-210, 2017.
Article in Czech | MEDLINE | ID: mdl-28593774

ABSTRACT

OBJECTIVE: The purpose of this study was to summarize our departments experience with pharmacological termination of pregnancy up to 49 days of amenorrhea, to assess the success, and especially, to offer a closer analysis of the complications of this method. DESIGN: Retrospective analysis. SETTING: Department of Gynaecology and Obstetrics at the Silesian Hospital. METHODS: The monitored sample consisted of 161 female patients who underwent pharmacological termination of pregnancy at our department from 1. 7. 2014 to 30. 6. 2016 being administered 600 mg of mifepristone (Mifegyne) and 400 µg of misoprostol (Mispregnol). Within the sample of patients we observed the objective process of pharmacological termination of pregnancy with special attention being payed to an analysis of complications. We compared the number of complications occurred under classic surgical intervention and those occurred under pharmacological termination of pregnancy. RESULTS: A complete abortion without the necessity of surgical intervention occurred with 151 patients (93.79%) of whom 15 patients with administering uterotonic medicaments. Ten patients (6.21%) required a consequent instrumental revision of the uterine cavity, seven of them (70%) had a history of surgical intervention in the uterine cavity. In case of one patient persisted vital pregnancy. Two patients underwent medical termination of pregnancy twice. In one case there were twins. CONCLUSION: The method of pharmacological pregnancy termination has a good efficiency, it is safe with minimal side effects.


Subject(s)
Abortifacient Agents, Nonsteroidal/administration & dosage , Abortifacient Agents/therapeutic use , Abortion, Induced/methods , Mifepristone/therapeutic use , Misoprostol/therapeutic use , Female , Humans , Mifepristone/administration & dosage , Misoprostol/administration & dosage , Pregnancy , Retrospective Studies , Treatment Outcome
3.
Ceska Gynekol ; 81(6): 458-462, 2016.
Article in Czech | MEDLINE | ID: mdl-27918165

ABSTRACT

OBJECTIVE: To present the findings of sarcoidosis on female genital tract. DESIGN: Review. SETTING: Department of Obstetric and Gynecology, Silesian Hospital Opava. METHODS: Overview of published findings from case studies. CONCLUSION: Sarcoidosis is a multisystem granulomatous disorder of unclear cause. It typically involves the lymph nodes of mediastinum, predominantly billateral and/or pulmonary infiltrates. We find extrapulmonary involvement in 30-50% of cases. Sarcoidosis of the female reproductive system is a rare, it represent less than 1% cases of sarcoidosis. Lesions there may affect any organ, including the vulva, vagina, cervix, uterus, fallopian tube and ovary, but also for example placenta and breast. There is also recorded the incidence of multiple localization on female genitalia. Since sarcoidosis of this area is so rare, often proceeds asymptomatic and recognized only as an incidental finding, there are mention only the case histories in literature yet.Clinical symptoms may be non-specific, often imitating a tumor, or tend to be specific, depending on the localization of disability such as perineal pain, pain in the scar after the previous birth trauma, persistent pruritus, itching, irritation, dyspareunia, menstrual cycle disorders, menorrhagia, metrorrhagia, postmenopausal bleeding, amenorrhoe, abdominal pain, endometrial polypoid lesions, recurrent or persistent serometra or discharge. The diagnosis is made up of histologically - we are demonstrating noncaseating granulomas.The therapy is difficult, there are no available official guidelines. If the lesions are clinically silent, we can observed them because they may spontaneously disappear. If we are embarking on medical therapy, we start from a local application, and if this is unsuccessful then we approach the systemic administration. Corticosteroids are the drug of choice. If we diagnose the sarcoidosis of the female genital organs we must exclude systemic disease of sarcoidosis. The prognosis of disease is good.


Subject(s)
Genital Diseases, Female/diagnosis , Sarcoidosis/diagnosis , Female , Genital Diseases, Female/drug therapy , Glucocorticoids/therapeutic use , Humans , Sarcoidosis/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...